ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

Three Cooperative Groups To Combine Statistical Center Operations

July 2, 2010

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006